Transplanted dopaminergic neurons develop PD pathologic changes: A second case report

Movement Disorders

Volumn 23, Issue 16, 2008, Pages 2303-2306

  Kordower, Jeffrey H ^a   Chu, Yaping ^a   Hauser, Robert A ^b   Olanow, C Warren ^c   Freeman, Thomas B ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Lewy body; Substantial nigra; Transplantation

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE TRANSPORTER; LEVODOPA; TYROSINE 3 MONOOXYGENASE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CELL TRANSPLANTATION; DEATH; DISEASE COURSE; DOPAMINERGIC NERVE CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; BRAIN; CELL TRANSPLANTATION; DOPAMINE; HUMANS; MALE; NEURONS; PARKINSON DISEASE; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 61449216234     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22369     Document Type: Article

References (9)

1. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008;14:504-506.
2. Li JY, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008;14:501-503.
3. Mendez I, Viñuela A, Astradsson A, et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 2008;14:507-509.
4. Hauser RA, Freeman TB, Snow BJ, et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease. Arch Neurol 1999;56:179-187.
5. Kordower JH, Rosenstein JM, Collier TJ, et al. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 1996;370:203-230.
6. Kordower JH, Styren S, Clarke M, DeKosky ST, Olanow CW, Freeman TB. Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant 1997;6:213-219.
7. Mendez I, Sanchez-Pernaute R, Cooper O, et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005;28(Part 7):1498-1510.
8. Panzacchi A, Moresco RM, Garibotto V, et al. A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset. Neurobiol Dis 2008;31:102-109.
9. Chu Y, Le W, Kompoliti K, Jancovic J, Mufson EJ, Kordower JH. Nurr1 in Parkinson's disease and related disorders. J Comp Neurol 2006;494:495-514.